Caroline Tillett - Aug 23, 2023 Form 4 Insider Report for Kenvue Inc. (KVUE)

Role
Chief Scientific Officer
Signature
/s/ Alla Berenshteyn, as attorney-in-fact
Stock symbol
KVUE
Transactions as of
Aug 23, 2023
Transactions value $
$0
Form type
4
Date filed
8/25/2023, 06:30 PM
Previous filing
May 8, 2023
Next filing
Oct 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KVUE Restricted Stock Units Award $0 +8.99K $0.00 8.99K Aug 23, 2023 Common Stock 8.99K Direct F1, F2
transaction KVUE Restricted Stock Units Award $0 +7.65K $0.00 7.65K Aug 23, 2023 Common Stock 7.65K Direct F1, F3
transaction KVUE Restricted Stock Units Award $0 +6.68K $0.00 6.68K Aug 23, 2023 Common Stock 6.68K Direct F1, F4
transaction KVUE Restricted Stock Units Award $0 +23.2K $0.00 23.2K Aug 23, 2023 Common Stock 23.2K Direct F5, F6
transaction KVUE Restricted Stock Units Award $0 +19.1K $0.00 19.1K Aug 23, 2023 Common Stock 19.1K Direct F3, F5
transaction KVUE Restricted Stock Units Award $0 +21.3K $0.00 21.3K Aug 23, 2023 Common Stock 21.3K Direct F4, F5
transaction KVUE Stock Options Award $0 +74.4K $0.00 74.4K Aug 23, 2023 Common Stock 74.4K $21.97 Direct F2, F7
transaction KVUE Stock Options Award $0 +75.5K $0.00 75.5K Aug 23, 2023 Common Stock 75.5K $22.40 Direct F3, F7
transaction KVUE Stock Options Award $0 +73.3K $0.00 73.3K Aug 23, 2023 Common Stock 73.3K $22.23 Direct F4, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value.
F2 This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date.
F3 This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date.
F4 This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date.
F5 These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years.
F6 This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date.
F7 These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value.